Humanis Saglık Anonim Sirketi
Quick facts
Marketed products
- Macitentan and Tadalafil
- Vonoprazan Tablets · Gastroenterology
Vonoprazan is a potassium-competitive acid blocker that reversibly inhibits the H+/K+-ATPase pump in gastric parietal cells to reduce gastric acid secretion.
Phase 1 pipeline
- Adempas Filmtabletten
- Bempedoic Acid Film Coated Tablet
- Bilastine oral dispersible tablets
- Bilaxten oral dispersible tablets
- Bosentan Dispersible Tablets
- Brexpiprazole Film Coated Tablets
- Chenodeoxycholic acid leadiant
- Empagliflozin film coated tablets
- Glyxambi film-coated tablets
- Jardiance film-coated tablets
- Nilemdo® Film-coated tablets
- Nuromol® tablets
- PrOpsynvi® Film-Coated Tablets
- Riociguat film coated tablets
- RXULTI film coated tablet
- Sacubitril and Valsartan-Reference product
- Sacubitril and Valsartan-Test product
- Segluromet film coated tablets
- Selexipag Film Coated Tablets
- Stromectol ® tablets
- Tenofovir Alafenamide Film coated Tablet
- Tivicay 50mg, film-coated tablets
- Tracleer Tablet for Oral Suspension
- Uptravi® Film Coated Tablets
- Vemlidy® film-coated tablets
- VOQUEZNA® Tablets
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: